Trovagene's Q1 Revenues Rise | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Trovagene reported after the close of the market Tuesday that its first-quarter revenues increased to $119,000 from $34,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.